Decoy Therapeutics (FP11) Q2 2023 Earnings Report
DE:FP11 Q2 2023 EPS Results
- Actual EPS
- -EUR 148.48
- Consensus EPS
- -EUR 134.64
- Beat/Miss
- Missed by -EUR 13.84
- One Year Ago EPS
- -EUR 233.63
DE:FP11 Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- After Close
- Conference Call
- Thursday, August 10, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:FP11 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2026 | 2025 (Q4) | ―- | -0.88 | ― | |
| Aug 06, 2025 | 2025 (Q2) | ―-5.86 | -30.79 | 80.98% (+24.94) | |
| May 08, 2025 | 2025 (Q1) | ―-0.89 | -0.35 | -150.49% (-0.53) | |
| Mar 24, 2025 | 2024 (Q4) | ―-13.18 | -22.84 | 42.28% (+9.66) | |
| Aug 07, 2024 | 2024 (Q2) | -46.38-2.05 | -9.9 | 79.28% (+7.85) | |
| May 09, 2024 | 2024 (Q1) | -5.80- | -1.93 | ― | |
| Mar 22, 2024 | 2023 (Q4) | -69.57-22.84 | -293.85 | 92.23% (+271.01) | |
| Nov 15, 2023 | 2023 (Q3) | -0.80-0.56 | -5.55 | 89.86% (+4.98) | |
| Aug 10, 2023 | 2023 (Q2) | -134.64-148.48 | -233.63 | 36.44% (+85.15) | |
| May 11, 2023 | 2023 (Q1) | -259.59-231.84 | -337.47 | 31.30% (+105.62) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
